Cargando…

Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022

Excess mortality studies provide crucial information regarding the health burden of pandemics and other large-scale events. Here, we use time series approaches to separate the direct contribution of SARS-CoV-2 infection on mortality from the indirect consequences of the pandemic in the United States...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wha-Eum, Woo Park, Sang, Weinberger, Daniel M, Olson, Donald, Simonsen, Lone, Grenfell, Bryan T, Viboud, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946455/
https://www.ncbi.nlm.nih.gov/pubmed/36811598
http://dx.doi.org/10.7554/eLife.77562
_version_ 1784892342264659968
author Lee, Wha-Eum
Woo Park, Sang
Weinberger, Daniel M
Olson, Donald
Simonsen, Lone
Grenfell, Bryan T
Viboud, Cécile
author_facet Lee, Wha-Eum
Woo Park, Sang
Weinberger, Daniel M
Olson, Donald
Simonsen, Lone
Grenfell, Bryan T
Viboud, Cécile
author_sort Lee, Wha-Eum
collection PubMed
description Excess mortality studies provide crucial information regarding the health burden of pandemics and other large-scale events. Here, we use time series approaches to separate the direct contribution of SARS-CoV-2 infection on mortality from the indirect consequences of the pandemic in the United States. We estimate excess deaths occurring above a seasonal baseline from March 1, 2020 to January 1, 2022, stratified by week, state, age, and underlying mortality condition (including COVID-19 and respiratory diseases; Alzheimer’s disease; cancer; cerebrovascular diseases; diabetes; heart diseases; and external causes, which include suicides, opioid overdoses, and accidents). Over the study period, we estimate an excess of 1,065,200 (95% Confidence Interval (CI) 909,800–1,218,000) all-cause deaths, of which 80% are reflected in official COVID-19 statistics. State-specific excess death estimates are highly correlated with SARS-CoV-2 serology, lending support to our approach. Mortality from 7 of the 8 studied conditions rose during the pandemic, with the exception of cancer. To separate the direct mortality consequences of SARS-CoV-2 infection from the indirect effects of the pandemic, we fit generalized additive models (GAM) to age- state- and cause-specific weekly excess mortality, using covariates representing direct (COVID-19 intensity) and indirect pandemic effects (hospital intensive care unit (ICU) occupancy and measures of interventions stringency). We find that 84% (95% CI 65–94%) of all-cause excess mortality can be statistically attributed to the direct impact of SARS-CoV-2 infection. We also estimate a large direct contribution of SARS-CoV-2 infection (≥67%) on mortality from diabetes, Alzheimer’s, heart diseases, and in all-cause mortality among individuals over 65 years. In contrast, indirect effects predominate in mortality from external causes and all-cause mortality among individuals under 44 years, with periods of stricter interventions associated with greater rises in mortality. Overall, on a national scale, the largest consequences of the COVID-19 pandemic are attributable to the direct impact of SARS-CoV-2 infections; yet, the secondary impacts dominate among younger age groups and in mortality from external causes. Further research on the drivers of indirect mortality is warranted as more detailed mortality data from this pandemic becomes available.
format Online
Article
Text
id pubmed-9946455
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-99464552023-02-23 Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022 Lee, Wha-Eum Woo Park, Sang Weinberger, Daniel M Olson, Donald Simonsen, Lone Grenfell, Bryan T Viboud, Cécile eLife Epidemiology and Global Health Excess mortality studies provide crucial information regarding the health burden of pandemics and other large-scale events. Here, we use time series approaches to separate the direct contribution of SARS-CoV-2 infection on mortality from the indirect consequences of the pandemic in the United States. We estimate excess deaths occurring above a seasonal baseline from March 1, 2020 to January 1, 2022, stratified by week, state, age, and underlying mortality condition (including COVID-19 and respiratory diseases; Alzheimer’s disease; cancer; cerebrovascular diseases; diabetes; heart diseases; and external causes, which include suicides, opioid overdoses, and accidents). Over the study period, we estimate an excess of 1,065,200 (95% Confidence Interval (CI) 909,800–1,218,000) all-cause deaths, of which 80% are reflected in official COVID-19 statistics. State-specific excess death estimates are highly correlated with SARS-CoV-2 serology, lending support to our approach. Mortality from 7 of the 8 studied conditions rose during the pandemic, with the exception of cancer. To separate the direct mortality consequences of SARS-CoV-2 infection from the indirect effects of the pandemic, we fit generalized additive models (GAM) to age- state- and cause-specific weekly excess mortality, using covariates representing direct (COVID-19 intensity) and indirect pandemic effects (hospital intensive care unit (ICU) occupancy and measures of interventions stringency). We find that 84% (95% CI 65–94%) of all-cause excess mortality can be statistically attributed to the direct impact of SARS-CoV-2 infection. We also estimate a large direct contribution of SARS-CoV-2 infection (≥67%) on mortality from diabetes, Alzheimer’s, heart diseases, and in all-cause mortality among individuals over 65 years. In contrast, indirect effects predominate in mortality from external causes and all-cause mortality among individuals under 44 years, with periods of stricter interventions associated with greater rises in mortality. Overall, on a national scale, the largest consequences of the COVID-19 pandemic are attributable to the direct impact of SARS-CoV-2 infections; yet, the secondary impacts dominate among younger age groups and in mortality from external causes. Further research on the drivers of indirect mortality is warranted as more detailed mortality data from this pandemic becomes available. eLife Sciences Publications, Ltd 2023-02-22 /pmc/articles/PMC9946455/ /pubmed/36811598 http://dx.doi.org/10.7554/eLife.77562 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication (https://creativecommons.org/publicdomain/zero/1.0/) .
spellingShingle Epidemiology and Global Health
Lee, Wha-Eum
Woo Park, Sang
Weinberger, Daniel M
Olson, Donald
Simonsen, Lone
Grenfell, Bryan T
Viboud, Cécile
Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022
title Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022
title_full Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022
title_fullStr Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022
title_full_unstemmed Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022
title_short Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022
title_sort direct and indirect mortality impacts of the covid-19 pandemic in the united states, march 1, 2020 to january 1, 2022
topic Epidemiology and Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946455/
https://www.ncbi.nlm.nih.gov/pubmed/36811598
http://dx.doi.org/10.7554/eLife.77562
work_keys_str_mv AT leewhaeum directandindirectmortalityimpactsofthecovid19pandemicintheunitedstatesmarch12020tojanuary12022
AT wooparksang directandindirectmortalityimpactsofthecovid19pandemicintheunitedstatesmarch12020tojanuary12022
AT weinbergerdanielm directandindirectmortalityimpactsofthecovid19pandemicintheunitedstatesmarch12020tojanuary12022
AT olsondonald directandindirectmortalityimpactsofthecovid19pandemicintheunitedstatesmarch12020tojanuary12022
AT simonsenlone directandindirectmortalityimpactsofthecovid19pandemicintheunitedstatesmarch12020tojanuary12022
AT grenfellbryant directandindirectmortalityimpactsofthecovid19pandemicintheunitedstatesmarch12020tojanuary12022
AT viboudcecile directandindirectmortalityimpactsofthecovid19pandemicintheunitedstatesmarch12020tojanuary12022